Healthy adult volunteers with a fasting blood glucose level in the normal range or the boundary range (less than 126 mg/dL).
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Systematic literature search using scientific databases and registered databases for clinical trials and systematic review will be performed. Key inclusion criteria as follows: Participants: Healthy adult volunteers with a fasting blood glucose level in the normal range or the boundary range (less than 126 mg/dL). Intervention: Intake the foods containing salacia-derived salacinol more than 0.02 mg/meal. Comparison: Intake the foods not containing salacia-derived salacinol. Outcome: The suppression effects of postprandial hyperglycemia (see above outcome column) Study design: Adopt randomized, quasi-randomized and non-randomized (parallel group or cross over) comparison test.
Exclusion criteria
Exclusion criteria: The literature which does not meet the key inclusion criteria will be excluded. Intervention tests without a placebo intake group are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the suppression effect on the postprandial hyperglycemia (ref1). Specifically, it is taken as the blood glucose level after ingestion of carbohydrate or a meal containing carbohydrate. (ref1) Since the fluctuation of blood glucose level after meals varies depending on the types or contents of carbohydrates loaded, such as a drink containing sucrose or a steamed rice, the primary outcome will be evaluated comprehensively using the Cmax and/or the area under the curve (AUC) of postprandial blood glucose level. | — |
Countries
Japan
Contacts
Association for Salacia Promotion Office